pubmed-article:21401339 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C0205208 | lld:lifeskim |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C1522240 | lld:lifeskim |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
pubmed-article:21401339 | lifeskim:mentions | umls-concept:C0332624 | lld:lifeskim |
pubmed-article:21401339 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:21401339 | pubmed:dateCreated | 2011-5-12 | lld:pubmed |
pubmed-article:21401339 | pubmed:abstractText | To investigate the physicochemical stability, pharmacokinetics (PK), and biodistribution of paclitaxel (PTX) from paclitaxel solid dispersion (PSD) prepared by supercritical antisolvent (SAS) process. | lld:pubmed |
pubmed-article:21401339 | pubmed:language | eng | lld:pubmed |
pubmed-article:21401339 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401339 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21401339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401339 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21401339 | pubmed:month | Jun | lld:pubmed |
pubmed-article:21401339 | pubmed:issn | 1520-5762 | lld:pubmed |
pubmed-article:21401339 | pubmed:author | pubmed-author:ParkJae-HyunJ... | lld:pubmed |
pubmed-article:21401339 | pubmed:author | pubmed-author:WooJong SooJS | lld:pubmed |
pubmed-article:21401339 | pubmed:author | pubmed-author:ChoiHan-GonHG | lld:pubmed |
pubmed-article:21401339 | pubmed:author | pubmed-author:YongChul... | lld:pubmed |
pubmed-article:21401339 | pubmed:author | pubmed-author:ChiSang-Cheol... | lld:pubmed |
pubmed-article:21401339 | pubmed:author | pubmed-author:ShanmugamSrin... | lld:pubmed |
pubmed-article:21401339 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21401339 | pubmed:volume | 37 | lld:pubmed |
pubmed-article:21401339 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21401339 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21401339 | pubmed:pagination | 628-37 | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:meshHeading | pubmed-meshheading:21401339... | lld:pubmed |
pubmed-article:21401339 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21401339 | pubmed:articleTitle | Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process. | lld:pubmed |
pubmed-article:21401339 | pubmed:affiliation | Pharm. R&D Institute, Hanmi Pharm. Co., Ltd., Hwasung, Gyeonggi 445-913, Republic of Korea. | lld:pubmed |
pubmed-article:21401339 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21401339 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |